Actively Recruiting
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Led by The Rogosin Institute · Updated on 2025-04-04
2000
Participants Needed
1
Research Sites
808 weeks
Total Duration
On this page
Sponsors
T
The Rogosin Institute
Lead Sponsor
N
New York Presbyterian Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.
CONDITIONS
Official Title
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females
- 18 years of age and older
- Willing and able to provide informed consent
- Require an initial kidney biopsy for medical necessity (Native Biopsy Tissue Group)
- Previously had a kidney biopsy and the tissue is not stored in this biorepository or have diabetes and kidney disease without biopsy (Native Kidney, Non-tissue Group)
- Have undergone a renal transplant and require a transplant biopsy for surveillance or "for-cause" reasons (Allograft Tissue Group)
You will not qualify if you...
- Inability to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Rogosin Institute
New York, New York, United States, 10021
Actively Recruiting
Research Team
N
Nelson Chen, M.A.
CONTACT
A
Alan Perlman, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here